Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-20 @ 10:42 PM
Study NCT ID:
NCT03469050
Status:
TERMINATED
Last Update Posted:
2021-10-20
First Post:
2018-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
Sponsor:
Alfasigma S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
REDIV/002/17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None